Terms: = Uterine cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
53 results:
1. Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-erk Signaling Pathway in Endometrial cancer Cells.
Tian S; Ren L; Liu C; Wang Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474453
[TBL] [Abstract] [Full Text] [Related]
2. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
4. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
5. Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through erk1/2/β-Catenin Pathway in Human Cervical cancer Cell Lines.
Hsin MC; Hsiao YH; Chen PN; Lin CW; Wang PH; Yang SF; Lee CY
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499426
[TBL] [Abstract] [Full Text] [Related]
6. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract] [Full Text] [Related]
7. CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of erk/JNK/p38-MAPK signaling pathways.
Xin W; Zhang J; Zhang H; Ma X; Zhang Y; Li Y; Wang F
BMC Mol Cell Biol; 2022 Oct; 23(1):44. PubMed ID: 36280802
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA THOR promotes endometrial cancer progression through the AKT and erk signaling pathways.
Zhang HQ; Li T; Li C; Hu HT; Zhu SM; Lu JQ; Chen XJ; Huang HF; Wu YT
Med Oncol; 2022 Sep; 39(12):207. PubMed ID: 36175594
[TBL] [Abstract] [Full Text] [Related]
9. EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/erk signaling pathway.
Li N; Ji GX; Yang ZY
Neoplasma; 2022 Sep; 69(5):1185-1197. PubMed ID: 36004647
[TBL] [Abstract] [Full Text] [Related]
10. An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
[TBL] [Abstract] [Full Text] [Related]
11. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y; Hiramatsu K; Funauchi M; Shiomi M; Masuda T; Kakuda M; Nakagawa S; Miyoshi A; Matsuzaki S; Kobayashi E; Kimura T; Serada S; Ueda Y; Naka T; Kimura T
BMC Cancer; 2022 Jun; 22(1):679. PubMed ID: 35729527
[TBL] [Abstract] [Full Text] [Related]
12. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/erk/c-Myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract] [Full Text] [Related]
13. Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.
Lin T; Wang W; Xu L; He Y
Arch Gynecol Obstet; 2022 Nov; 306(5):1703-1709. PubMed ID: 35394200
[TBL] [Abstract] [Full Text] [Related]
14. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.
Zhang Y; Li N; Yuan G; Yao H; Zhang D; Li N; Zhang G; Sun Y; Wang W; Zeng J; Xu N; Liu M; Wu L
BMC Med; 2022 Feb; 20(1):55. PubMed ID: 35130902
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/erk signaling.
Zhu K; Bai H; Mu M; Xue Y; Duan Z
FEBS Open Bio; 2021 Jul; 11(7):2041-2049. PubMed ID: 34081837
[TBL] [Abstract] [Full Text] [Related]
16. CircFAT1 facilitates cervical cancer malignant progression by regulating erk1/2 and p38 MAPK pathway through miR-409-3p/CDK8 axis.
Zhou B; Li T; Xie R; Zhou J; Liu J; Luo Y; Zhang X
Drug Dev Res; 2021 Dec; 82(8):1131-1143. PubMed ID: 33818788
[TBL] [Abstract] [Full Text] [Related]
17. BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of erk/MEK signaling pathway.
Lu Y; Lu H; Yang X; Song W
Reprod Biol; 2021 Jun; 21(2):100502. PubMed ID: 33784561
[TBL] [Abstract] [Full Text] [Related]
18. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract] [Full Text] [Related]
19. A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix.
Li H; Jing X; Yu J; Liu J; Zhang T; Chen S; Zhang X
Diagn Pathol; 2020 Aug; 15(1):104. PubMed ID: 32843061
[TBL] [Abstract] [Full Text] [Related]
20. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract] [Full Text] [Related]
[Next]